+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Ophthalmic Implants Market - Global Outlook & Forecast 2022-2027

  • PDF Icon

    Report

  • 265 Pages
  • April 2022
  • Region: Global
  • Arizton
  • ID: 5575365
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Ophthalmic Implants Market Report

The ophthalmic implants market size is expected to grow at a CAGR of 6.5%.

MARKET GROWTH ENABLERS

  • Growing Advancements in Ophthalmic Diagnostic Technology
  • Increasing Adoption of Advanced Ocular Devices
  • Increase in the Number of Cases Of Eye-Related Disorders
  • Rise In Awareness of Diagnosis & Treatment of Eye Disorders
  • Launches and approvals to Increase Market Share
  • In May 2020, the launch of the presbyopia-correcting intraocular lens (IOL) LuxSmart and its monofocal version LuxGood was announced. Both have pre-loaded delivery systems and Pure Refractive Optics (PRO) technology.
  • In January 2021, the AcrySof IQ Vivity IOL (Vivity), the non-diffractive intraocular lens with extended depth of field (IOL), was launched in the US. Vivity is used in the AcrySof IQ IOL.

GLOBAL OPHTHALMIC IMPLANTS MARKET SEGMENTATION ANALYSIS


The Intraocular Lenses are expected to witness the highest incremental growth and Glaucoma Implants are likely to witness the highest absolute growth during the forecast period. The rising cases of presbyopia, myopia, blindness, cataract surgery, and farsightedness are expected to drive demand for the global eye implant market. Other major reasons for the market's growth include increasing awareness of comprehensive eye care services, the surge in the geriatric population, and the inclusion of eye care services in the insurance system. The total number of patients undergoing cataract surgery has more than tripled in a decade, a key factor that has impacted players in the intraocular lens industry.

Hospitals are expected to witness the highest incremental growth during the forecast period. The Hospital segment is the dominant segment in the ophthalmic implant market. Glaucoma drainage implant surgery is performed in an outpatient surgery center or hospital.

Market Segmentation by Product

  • Intraocular Lenses
  • Glaucoma Implants
  • Corneal Implants
  • Others

Market Segmentation by Application

  • CATARACT SURGERY
  • GLAUCOMA SURGERY
  • OTHERS

Market Segmentation by End-User

  • Hospitals
  • Ambulatory Surgery Centers
  • Ophthalmic Clinics

VENDOR LANDSCAPE


Advances in ophthalmic diagnostic technology have resulted in wider product adoption. The easy accessibility of online tools has educated the public about various treatment options and will help the market grow. The increasing acceptance of advanced ocular devices such as artificial eyes and glaucoma devices has opened up the potential for companies active in the market. The increasing number of regulatory approvals for corneal implants devices will help large companies generate significant revenue in the eye implant market in the years to come. The emergence of various advanced intraocular lenses and increased competition between manufacturers to develop better lenses, as well as an increase in investment in eye research institutes by government and non-governmental organizations are expected to fuel market growth.

Key Vendors

  • ALCON
  • Johnson & Johnson
  • Bausch & Lomb

Other Prominent Vendors

  • Second Sight
  • Micro Engineering Solutions
  • Gulden Ophthalmic
  • AJL Ophthalmic S.A
  • EyeD Pharma
  • Care Group
  • F. Ad. Müller Söhne Gmbh & Co.KG
  • Hoya Corporation
  • MORCHER GmbH
  • Ophtec BV
  • BVI
  • Rayner Intraocular Lenses Limited
  • Glaukos Corporation
  • CorNeat Vision
  • HumanOptics
  • Omni Lens
  • IVANTIS
  • InnFocus
  • POLYACTIVA PTY LTD
  • LAMBDAVISION
  • SMR OPHTHALMIC PVT. LTD
  • Labtician Ophthalmics, Inc
  • Devine Meditech
  • Innolens
  • iSTAR Medical

GEOGRAPHIC OVERVIEW


The increasing ageing population and raising awareness in the North American region are expected to drive the ophthalmic implants market size in the region.

Market Segmentation by Region

  • Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • North America
  • US
  • Canada
  • APAC
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Latin America
  • Mexico
  • Argentina
  • Brazil
  • Middle East and Africa
  • Turkey
  • Saudi Arabia
  • South Africa

THE REPORT INCLUDES:


1. The analysis of the global Ophthalmic Implants market provides market size and growth rate for the forecast period 2022-2027.
2. It offers comprehensive insights into current industry trends, trend forecast, and growth drivers about the global Ophthalmic Implants market.
3. The report provides the latest analysis of market share, growth drivers, challenges, and investment opportunities.
4. It offers a complete overview of market segments and the regional outlook of the Ophthalmic Implants market.
5. The report offers a detailed overview of the vendor landscape, competitive analysis, and critical market strategies to gain competitive advantage.

Table of Contents

1 Research Methodology2 Research Objectives3 Research Process
4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.1.3 Market Estimation Caveats
4.2 Base Year
4.3 Scope of the Study
4.3.1 Market Segmentation by Product
4.3.2 Market Segmentation by Application
4.3.3 Market Segmentation by End-User
4.3.4 Market Segmentation by Geography
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 Market at a Glance
7 Introduction
7.1 Overview
7.2 Impact of Covid-19
8 Market Opportunities & Trends
8.1 Rise of Artificial Intelligence for Detecting Diabetic Retinopathy
8.2 Use of Synthetic Cornea Implants
8.3 Increase in Use of Robotic Surgical Assistants for Eye Surgeries
9 Market Growth Enablers
9.1 Growing Advancements in Ophthalmic Diagnostic Technology
9.2 Increasing Adoption of Advanced Ocular Devices
9.3 Increase in the Number of Cases of Eye-Related Disorders
9.4 Rise in Awareness of Diagnosis & Treatment of Eye Disorders
9.5 Rise in Preference for Minimally Invasive Ophthalmic Surgery
10 Market Restraints
10.1 Stringent Regulatory Approvals and Product Recalls
10.2 Increase in Risk of Surgery Failure
11 Market Landscape
11.1 Market Overview
11.2 Market Size & Forecast
11.2.1 Market Share by Product
11.2.2 Market Share by Application
11.2.3 Market Share by End-User
11.2.4 Market Share by Geography
11.3 Five Forces Analysis
11.3.1 Threat of New Entrants
11.3.2 Bargaining Power of Suppliers
11.3.3 Bargaining Power of Buyers
11.3.4 Threat of Substitutes
11.3.5 Competitive Rivalry
12 Product
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 Intraocular Lenses
12.3.1 Market Overview
12.3.2 Market Size & Forecast
12.3.3 Intraocular Lenses: Market by Geography
12.4 Glaucoma Implants
12.4.1 Market Overview
12.4.2 Market Size & Forecast
12.4.3 Glaucoma Implants: Market by Geography
12.5 Corneal Implants
12.5.1 Market Overview
12.5.2 Market Size & Forecast
12.5.3 Corneal Implants: Market by Geography
12.6 Others
12.6.1 Market Overview
12.6.2 Market Size & Forecast
12.6.3 Others: Market by Geography
13 Application
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Cataract Surgery
13.3.1 Market Overview
13.3.2 Market Size & Forecast
13.3.3 Cataract Surgery: Market by Geography
13.4 Glaucoma Surgery
13.4.1 Market Overview
13.4.2 Market Size & Forecast
13.4.3 Glaucoma Surgery: Market by Geography
13.5 Others
13.5.1 Market Overview
13.5.2 Market Size & Forecast
13.5.3 Others: Market by Geography
14 End-User
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Hospitals
14.3.1 Market Overview
14.3.2 Market Size & Forecast
14.3.3 Hospitals: Market by Geography
14.4 Ambulatory Surgery Centers
14.4.1 Market Overview
14.4.2 Market Size & Forecast
14.4.3 Ambulatory Surgery Centers: Market by Geography
14.5 Ophthalmic Clinics
14.5.1 Market Overview
14.5.2 Market Size & Forecast
14.5.3 Ophthalmic Clinics: Market by Geography
15 Geography
15.1 Market Snapshot & Growth Engine
15.2 Geographic Overview
16 North America
16.1 Market Overview
16.2 Market Size & Forecast
16.3 North America: Product Segmentation
16.4 North America: Application Segmentation
16.5 North America: End-User Segmentation
16.6 North America: Key Countries
16.6.1 Us: Market Size & Forecast
16.6.2 Canada: Market Size & Forecast
17 Europe
17.1 Market Overview
17.2 Market Size & Forecast
17.3 Europe: Product Segmentation
17.4 Europe: Application Segmentation
17.5 Europe: End-User Segmentation
17.6 Europe: Key Countries
17.6.1 Germany: Market Size & Forecast
17.6.2 Uk: Market Size & Forecast
17.6.3 France: Market Size & Forecast
17.6.4 Spain: Market Size & Forecast
17.6.5 Italy: Market Size & Forecast
18 Apac
18.1 Market Overview
18.2 Market Size & Forecast
18.3 Apac: Product Segmentation
18.4 Apac: Application Segmentation
18.5 Apac: End-User Segmentation
18.6 Apac: Key Countries
18.6.1 China: Market Size & Forecast
18.6.2 Japan: Market Size & Forecast
18.6.3 India: Market Size & Forecast
18.6.4 Australia: Market Size & Forecast
18.6.5 South Korea: Market Size & Forecast
19 Latin America
19.1 Market Overview
19.2 Market Size & Forecast
19.3 Latin America: Product Segmentation
19.4 Latin America: Application Segmentation
19.5 Latin America: End-User Segmentation
19.6 Latin America: Key Countries
19.6.1 Mexico: Market Size & Forecast
19.6.2 Argentina: Market Size & Forecast
19.6.3 Brazil: Market Size & Forecast
20 Middle East & Africa
20.1 Market Overview
20.2 Market Size & Forecast
20.3 Middle East & Africa: Product Segmentation
20.4 Middle East & Africa: Application Segmentation
20.5 Middle East & Africa: End-User Segmentation
20.6 Middle East & Africa: Key Countries
20.6.1 Turkey: Market Size & Forecast
20.6.2 Saudi Arabia: Market Size & Forecast
20.6.3 South Africa: Market Size & Forecast
21 Competitive Landscape
21.1 Competition Overview
21.2 Market Share Analysis
21.2.1 Alcon
21.2.2 Johnson & Johnson Vision
21.2.3 Bausch & Lomb
21.2.4 Carl Zeiss
22 Prominent Vendors
22.1 Alcon
22.1.1 Business Overview
22.1.2 Product Offerings
22.1.3 Key Strategies
22.1.4 Key Strengths
22.1.5 Key Opportunities
22.2 Johnson & Johnson
22.2.1 Business Overview
22.2.2 Product Offerings
22.2.3 Key Strategies
22.2.4 Key Strengths
22.2.5 Key Opportunities
22.3 Bausch & Lomb
22.3.1 Business Overview
22.3.2 Product Offerings
22.3.3 Key Strategies
22.3.4 Key Strengths
22.3.5 Key Opportunities
23 Other Prominent Vendors
23.1 Second Sight
23.1.1 Business Overview
23.1.2 Product Offerings
23.2 Micro Engineering Solutions
23.2.1 Business Overview
23.2.2 Product Offerings
23.3 Gulden Ophthalmics
23.3.1 Business Overview
23.3.2 Product Offerings
23.4 Ajl Ophthalmic S.A
23.4.1 Business Overview
23.4.2 Product Offerings
23.5 Eyed Pharma
23.5.1 Business Overview
23.5.2 Product Offerings
23.6 Care Group
23.6.1 Business Overview
23.6.2 Product Offerings
23.7 F.Ad. Müller Söhne GmbH & Co.Kg
23.7.1 Business Overview
23.7.2 Product Offerings
23.8 Hoya Corporation
23.8.1 Business Overview
23.8.2 Product Offering
23.9 Morcher GmbH
23.9.1 Business Overview
23.9.2 Product Offerings
23.10 Ophtec
23.10.1 Business Overview
23.10.2 Product Offerings
23.11 Bvi
23.11.1 Business Overview
23.11.2 Product Offerings
23.12 Rayner Intraocular Lenses Limited
23.12.1 Business Overview
23.12.2 Product Offerings
23.13 Glaukos Corporation
23.13.1 Business Overview
23.13.2 Product Offerings
23.14 Corneat Vision
23.14.1 Business Overview
23.14.2 Product Offerings
23.15 Humanoptics
23.15.1 Business Overview
23.15.2 Product Offerings
23.16 Omni Lens
23.16.1 Business Overview
23.16.2 Product Offerings
23.17 Ivantis
23.17.1 Business Overview
23.17.2 Product Offerings
23.18 Innfocus
23.18.1 Business Overview
23.18.2 Product Offerings
23.19 Polyactiva Pty Ltd
23.19.1 Business Overview
23.19.2 Product Offerings
23.20 Lambdavision
23.20.1 Business Overview
23.20.2 Product Offerings
23.21 Smr Ophthalmic Pvt. Ltd.
23.21.1 Business Overview
23.21.2 Product Offerings
23.22 Labtician Ophthalmics, Inc.
23.22.1 Business Overview
23.22.2 Product Offerings
23.23 Devine Meditech
23.23.1 Business Overview
23.23.2 Product Offerings
23.24 Innolens
23.24.1 Business Overview
23.24.2 Product Offerings
23.25 Istar Medical
23.25.1 Business Overview
23.25.2 Product Offerings
24 Report Summary
24.1 Key Takeaways
24.2 Strategic Recommendations
25 Quantitative Summary
25.1 Market by Geography
25.2 Market by Product
25.3 Market by Application
25.4 Market by End-User
25.5 North America: by Product
25.6 North America: by Application
25.7 North America: by End-User
25.8 Europe: by Product
25.9 Europe: by Application
25.10 Europe: by End-User
25.11 Apac: by Product
25.12 Apac: by Application
25.13 Apac: by End-User
25.14 Latin America: by Product
25.15 Latin America: by Application
25.16 Latin America: by End-User
25.17 Middle East & Africa: by Product
25.18 Middle East & Africa: by Application
25.19 Middle East & Africa: by End-User
26 Appendix
26.1 Abbreviations

Companies Mentioned

  • ALCON
  • Johnson & Johnson
  • Bausch & Lomb
  • Second Sight
  • Micro Engineering Solutions
  • Gulden Ophthalmic
  • AJL Ophthalmic S.A
  • EyeD Pharma
  • Care Group
  • F. Ad. Müller Söhne Gmbh & Co.KG
  • Hoya Corporation
  • MORCHER GmbH
  • Ophtec BV
  • BVI
  • Rayner Intraocular Lenses Limited
  • Glaukos Corporation
  • CorNeat Vision
  • HumanOptics
  • Omni Lens
  • IVANTIS
  • InnFocus
  • POLYACTIVA PTY LTD
  • LAMBDAVISION
  • SMR OPHTHALMIC PVT. LTD
  • Labtician Ophthalmics, Inc
  • Devine Meditech
  • Innolens
  • iSTAR Medical

Methodology


Our research comprises a mix of primary and secondary research. The secondary research sources that are typically referred to include, but are not limited to, company websites, annual reports, financial reports, company pipeline charts, broker reports, investor presentations and SEC filings, journals and conferences, internal proprietary databases, news articles, press releases, and webcasts specific to the companies operating in any given market.

Primary research involves email interactions with the industry participants across major geographies. The participants who typically take part in such a process include, but are not limited to, CEOs, VPs, business development managers, market intelligence managers, and national sales managers. We primarily rely on internal research work and internal databases that we have populated over the years. We cross-verify our secondary research findings with the primary respondents participating in the study.



 

Loading
LOADING...